Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

360 ARTÍCULOS , VIENDO DEL 211 AL 225

Guiding research and practice: a conceptual model for aerobic exercise training in Alzheimer's disease

Fang Yu.

Am J Alzheimers Dis Other Demen. 2011 May;26(3):184-94. doi: 10.1177/1533317511402317. Epub 2011 Mar 23.

[Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]

Shioda N, Yamamoto Y, Han F, Moriguchi S, Fukunaga K.

Yakugaku Zasshi. 2011 Apr;131(4):505-11. doi: 10.1248/yakushi.131.505.

The involvement of multiple caregivers in cognitive-behavior therapy for anxiety in persons with dementia

Robinson CM, Paukert A, Kraus-Schuman CA, Snow AL, Kunik ME, Wilson NL, Teri L, Stanley MA.

Aging Ment Health. 2011 Apr;15(3):291-8. doi: 10.1080/13607860903493374.

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study

Barak Y, Plopski I, Tadger S, Paleacu D.

Int Psychogeriatr. 2011 Nov;23(9):1515-9. doi: 10.1017/S1041610211000743. Epub 2011 Apr 15.

Persons with mild or moderate Alzheimer's disease use a basic orientation technology to travel to different rooms within a day center

Lancioni GE, Perilli V, Singh NN, O'Reilly MF, Sigafoos J, Bosco A, De Caro MF, Cassano G, Pinto K, Minervini M.

Res Dev Disabil. 2011 Sep-Oct;32(5):1895-901. doi: 10.1016/j.ridd.2011.03.020. Epub 2011 Apr 17.

A phase II trial of huperzine A in mild to moderate Alzheimer disease

Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Apr 19;76(16):1389-94. doi: 10.1212/WNL.0b013e318216eb7b.

Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients

Hattori H, Hattori C, Hokao C, Mizushima K, Mase T.

Geriatr Gerontol Int. 2011 Oct;11(4):431-7. doi: 10.1111/j.1447-0594.2011.00698.x. Epub 2011 Apr 26.

Alzheimer's disease management guideline: update 2008

Segal-Gidan F, Cherry D, Jones R, Williams B, Hewett L, Chodosh J; California Workgroup on Guidelines for Alzheimer's Disease Management.

Alzheimers Dement. 2011 May;7(3):e51-9. doi: 10.1016/j.jalz.2010.07.005. Epub 2011 May 5.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD

Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.

Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.

Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task

Miettinen PS, Pihlajamäki M, Jauhiainen AM, Tarkka IM, Gröhn H, Niskanen E, Hänninen T, Vanninen R, Soininen H.

Curr Alzheimer Res. 2011 Nov;8(7):753-64. doi: 10.2174/156720511797633241.

[Efficacy of an occupational group therapy in degenerative dementias: a controlled study in the nursing home setting]

Pickel S, Grässel E, Luttenberger K.

Psychiatr Prax. 2011 Nov;38(8):389-96. doi: 10.1055/s-0030-1266137. Epub 2011 May 19.

Galantamine and behavior in Alzheimer disease: analysis of four trials

Kavanagh S, Gaudig M, Van Baelen B, Adami M, Delgado A, Guzman C, Jedenius E, Schäuble B.

Acta Neurol Scand. 2011 Nov;124(5):302-8. doi: 10.1111/j.1600-0404.2011.01525.x. Epub 2011 May 26.

Bionanotechnologies for treatment and diagnosis of Alzheimer's disease

Moghimi SM.

Nanomedicine. 2011 Oct;7(5):515-8. doi: 10.1016/j.nano.2011.05.001. Epub 2011 May 17.

Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer's disease

Shi JQ, Wang BR, Jiang WW, Chen J, Zhu YW, Zhong LL, Zhang YD, Xu J.

J Am Geriatr Soc. 2011 Jun;59(6):1142-4. doi: 10.1111/j.1532-5415.2011.03445.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias